Literature DB >> 34028504

Effectiveness of Tocilizumab in Patients Hospitalized With COVID-19: A Follow-up of the CORIMUNO-TOCI-1 Randomized Clinical Trial.

Xavier Mariette1,2, Olivier Hermine3,4, Pierre-Louis Tharaux5, Matthieu Resche-Rigon6,7, Philippe Gabriel Steg8,9, Raphaël Porcher10, Philippe Ravaud10,11.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34028504      PMCID: PMC8145157          DOI: 10.1001/jamainternmed.2021.2209

Source DB:  PubMed          Journal:  JAMA Intern Med        ISSN: 2168-6106            Impact factor:   44.409


× No keyword cloud information.
  23 in total

Review 1.  The AI-Assisted Identification and Clinical Efficacy of Baricitinib in the Treatment of COVID-19.

Authors:  Peter J Richardson; Bruce W S Robinson; Daniel P Smith; Justin Stebbing
Journal:  Vaccines (Basel)       Date:  2022-06-15

2.  A pilot phase Ib/II study of whole-lung low dose radiation therapy (LDRT) for the treatment of severe COVID-19 pneumonia: First experience from Africa.

Authors:  Mansoor Saleh; Karishma Sharma; Jasmit Shah; Farrok Karsan; Angela Waweru; Martin Musumbi; Reena Shah; Shahin Sayed; Innocent Abayo; Noureen Karimi; Stacey Gondi; Sehrish Rupani; Grace Kirathe; Heldah Amariati
Journal:  PLoS One       Date:  2022-07-01       Impact factor: 3.752

Review 3.  Passive Immunotherapy Against SARS-CoV-2: From Plasma-Based Therapy to Single Potent Antibodies in the Race to Stay Ahead of the Variants.

Authors:  William R Strohl; Zhiqiang Ku; Zhiqiang An; Stephen F Carroll; Bruce A Keyt; Lila M Strohl
Journal:  BioDrugs       Date:  2022-04-27       Impact factor: 7.744

4.  Efficacy of Single Tocilizumab Administration in an 88-Year-Old Patient with Severe COVID-19 and a Mini Literature Review.

Authors:  Cid Ould Ouali; Nadia Ladjouzi; Khidher Tamas; Hendriniaina Raveloson; Jihene Ben Hassen; Nesrine El Omeiri; Georges Zouloumis; Mohamed Moataz Al Zoabi; Muneer Asadi; Aziza Jhouri; Joël Schlatter
Journal:  Geriatrics (Basel)       Date:  2022-02-21

5.  Immunomodulatory therapies for the treatment of SARS-CoV-2 infection: an update of the systematic literature review to inform EULAR points to consider.

Authors:  Alessia Alunno; Aurélie Najm; Xavier Mariette; Gabriele De Marco; Jenny Emmel; Laura Mason; Dennis G McGonagle; Pedro M Machado
Journal:  RMD Open       Date:  2021-10

Review 6.  A comparison between virus- versus patients-centred therapeutic attempts to reduce COVID-19 mortality.

Authors:  Serge Camelo; Mathilde Latil; Sam Agus; Waly Dioh; Stanislas Veillet; René Lafont; Pierre J Dilda
Journal:  Emerg Microbes Infect       Date:  2021-12       Impact factor: 7.163

7.  Tocilizumab and SARS-CoV-2 (COVID-19): An Evolving Story, the Picture Is Clearer.

Authors:  Larry M Bush; Justin Williams; Evan Stutchin
Journal:  Infect Dis Clin Pract (Baltim Md)       Date:  2021-07-08

Review 8.  Bowel ischemia in COVID-19: A systematic review.

Authors:  Suyog Patel; Charmy Parikh; Deepak Verma; Ramaswamy Sundararajan; Upasana Agrawal; Niharika Bheemisetty; Radhika Akku; Diana Sánchez-Velazco; Madeeha Subhan Waleed
Journal:  Int J Clin Pract       Date:  2021-10-10       Impact factor: 3.149

Review 9.  Tocilizumab in patients with COVID-19: which patient, time, and dose?

Authors:  Ahmed Hasanin; Maha Mostafa
Journal:  J Anesth       Date:  2021-07-15       Impact factor: 2.078

10.  "L'histoire se répète", one size does not fit all.

Authors:  Marnix Kuindersma; Peter E Spronk
Journal:  Intensive Care Med       Date:  2021-07-20       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.